Načítá se...
Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness
Genetic variants account for approximately half the cases of congenital and early‐onset deafness. Methods and technologies for viral delivery of genes into the inner ear have evolved over the past decade to render gene therapy a viable and attractive approach for treatment. Variants in SYNE4, encodi...
Uloženo v:
| Vydáno v: | EMBO Mol Med |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863404/ https://ncbi.nlm.nih.gov/pubmed/33350593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013259 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|